![John Carpten: City of Hope’s national strategy drew me to this opportunity](https://cdn.cancerletter.com/media/2023/11/10151443/49-42-4x3-1.jpg)
![John Carpten: City of Hope’s national strategy drew me to this opportunity](https://cdn.cancerletter.com/media/2023/11/10151443/49-42-4x3-1.jpg)
Cover Story
Conversation with The Cancer LetterFree
John Carpten, when he was named director of the City of Hope Comprehensive Cancer Center in April, took over a massive, newly formed national oncology network—the first of its kind.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
Trending Stories
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- What are you reading in 2023?
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence